Genetic Disorder News and Research

RSS
UCSF protein researcher wins NIH's Early Independence Award

UCSF protein researcher wins NIH's Early Independence Award

Lovastatin appears to be safe, effective for children with neurofibromatosis type 1

Lovastatin appears to be safe, effective for children with neurofibromatosis type 1

Two computerized tests increase ability to detect remaining vision in patients with RP

Two computerized tests increase ability to detect remaining vision in patients with RP

Afraxis to participate in NIH's Therapeutics for Rare and Neglected Disease Program

Afraxis to participate in NIH's Therapeutics for Rare and Neglected Disease Program

Afinitor Phase III study on angiomyolipomas associated with TSC meets primary endpoint

Afinitor Phase III study on angiomyolipomas associated with TSC meets primary endpoint

EMA CHMP adopts positive opinion for Soliris to treat atypical hemolytic uremic syndrome

EMA CHMP adopts positive opinion for Soliris to treat atypical hemolytic uremic syndrome

Cedars-Sinai inaugurates new facility to generate induced pluripotent stem cells

Cedars-Sinai inaugurates new facility to generate induced pluripotent stem cells

AGTC receives FFB grant to evaluate gene therapy treatment for X-linked Retinoschisis

AGTC receives FFB grant to evaluate gene therapy treatment for X-linked Retinoschisis

First ever domino liver transplant

First ever domino liver transplant

Regular exercise also increases mitochondrial numbers in brain cells

Regular exercise also increases mitochondrial numbers in brain cells

Landmark international study confirms common genetic contribution to mental illness

Landmark international study confirms common genetic contribution to mental illness

Scientists uncover unknown fail-safe pathway for inherited disorders

Scientists uncover unknown fail-safe pathway for inherited disorders

Health Canada approves Afinitor for treatment of brain tumours caused by TSC in children

Health Canada approves Afinitor for treatment of brain tumours caused by TSC in children

ViroPharma initiates Cinryze Phase 2 subcutaneous trial in patients with HAE

ViroPharma initiates Cinryze Phase 2 subcutaneous trial in patients with HAE

Roche initiates Phase 1 clinical trial of investigational drug for Down syndrome

Roche initiates Phase 1 clinical trial of investigational drug for Down syndrome

New treatment strategy for dominant forms of muscular dystrophy

New treatment strategy for dominant forms of muscular dystrophy

London scientist hopes to improve diagnosis for Jeune syndrome

London scientist hopes to improve diagnosis for Jeune syndrome

New blood test could help identify babies at risk of sickle cell disease

New blood test could help identify babies at risk of sickle cell disease

Robert Gordon University scientists to develop new treatment for cystinosis

Robert Gordon University scientists to develop new treatment for cystinosis

PTC restructures collaboration with Genzyme

PTC restructures collaboration with Genzyme

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.